Dong Jun Lee is listed as an executive officer on 1 SEC Form D filing by 1 issuer in Jan 2026: US Pharmatech Inc. (Cerritos, CA — manufacturing — 2026; $3.4M reported sold to 1 investors).
What this means One deal on file with the SEC, filed Jan 2026. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
No other person or management entity is listed on the same filings.
What this means The filings name this person alone — no co-officers, directors or promoters were listed.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 1 public filing for Dong Jun Lee and found 2 differences: Form D filed 16 days after the first sale; Same name, different state: "Dong Jae Lee" (DE) is a separate record.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.